These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effects of cadralazine on contractions induced by Ca2+ and norepinephrine in isolated rabbit aortic strips.
    Author: Higashio T, Kuroda K.
    Journal: Arzneimittelforschung; 1988 Mar; 38(3):346-9. PubMed ID: 3382458.
    Abstract:
    Antagonistic effects of the new antihypertensive agent cadralazine (ethyl(+/-)-6-[ethyl(2-hydroxypropyl)-amino]-3-pyridazinecarbazate ) and its metabolite ISF-2405 [+/-)-6-[ethyl(2-hydroxypropyl)amino]-3-hydrazinopyridazine) on contractile responses to CaCl2 in K+-depolarised medium and to norepinephrine (NE) in Ca2+-free medium were compared with those of hydralazine using isolated rabbit abdominal aortic strips. Even at high doses of cadralazine (10(-4) mol/l), ISF-2405 (10(-5) mol/l) and hydralazine (10(-5) mol/l), only less than 10% inhibition was observed on dose-dependent contractions induced by CaCl2, 0.05 to 6.4 mmol/l, in K+ 40 mmol/l medium. NE produced dose-dependent contractions even in Ca2+-free medium at concentrations of 10(-9) to 3 X 10(-5) mol/l, and the maximal response was diminished to about 45% of the response in the presence of Ca2+. Cadralazine 10(-4) mol/l exerted no effect on Ca2+-free NE-induced contractions, while ISF-2405 and hydralazine at concentrations of 10(-7) to 10(-5) mol/l were equipotent, showing marked dose-dependent, non-competitive inhibition on NE-induced contractions. These results suggest that ISF-2405 and hydralazine show vasodilating effect through the inhibition of the Ca2+-release from intracellular storage but not via inhibition of the potential dependent Ca2+ influx.
    [Abstract] [Full Text] [Related] [New Search]